Merkel cell polyomavirus (MCV) causes an aggressive human skin cancer, Merkel cell carcinoma, through expression of small T (sT) and large T (LT) viral oncoproteins. MCV sT is also required for efficient MCV DNA replication by the multifunctional MCV LT helicase protein. We find that LT is targeted for proteasomal degradation by the cellular SCF Fbw7 E3 ligase, which can be inhibited by sT through its LT stabilization domain (LSD). Consequently, sT also stabilizes cellular SCF Fbw7 targets, including the cell cycle regulators c-Myc and cyclin E. Mutating the sT LSD decreases LT protein levels and eliminates synergism in MCV DNA replication as well as sT-induced cell transformation. SCF Fbw7 knockdown mimics sT-mediated stabilization of LT, but this knockdown is insufficient to fully reconstitute the transforming activity of a mutant LSD sT protein. Thus, MCV has evolved a regulatory system involving SCF Fbw7 that controls viral replication but also contributes to host cell transformation.
INTRODUCTION
C-terminally truncated MCV LT antigen promotes tumorigenesis in human Merkel cells. Both LT and sT antigens are required for MCV-positive MCC cell survival and proliferation (Houben et al., 2012; Houben et al., 2010; Shuda et al., 2011) . In in vitro cell transformation assays, MCV sT is sufficient to transform rodent fibroblasts in culture whereas MCV LT cannot (Shuda et al., 2011) . This is in marked contrast to the more well-known polyomavirus SV40, in which SV40 LT is the major transforming oncoprotein while sT promotes cell transformation (Hahn et al., 2002) but is not fully transforming on its own (Bikel et al., 1987) .
A comparison of the cellular targets of SV40 and MCV viral sT proteins shows similarities as well as differences. Both MCV and SV40 sT target protein phosphatase 2A (PP2A) and heat-shock proteins through direct protein-protein interactions. SV40 sT prevents PP2A dephosphorylation of Akt whereas MCV sT has minimal effect at this node of the AktmTOR signaling pathway (Shuda et al., 2011) . MCV sT, instead, acts downstream of mTOR to increase levels of hyper-phosphorylated 4E-BP1, a regulator of cap-dependent translation. MCV sT-induced cell transformation is independent of PP2A binding but can be inhibited by a constitutively-active mutant 4E-BP1 protein. In contrast, SV40 sT has been reported to diminish 4E-BP1 phosphorylation (Yu et al., 2005) .
MCV sT also plays a key role in promoting MCV genome replication. MCV LT assembles on a 71 base pair stretch of the viral replication origin by recognizing specific pentanucleotide sequence repeats (Harrison et al., 2011; Kwun et al., 2009 ). For SV40, sT coexpression has minimal effect on SV40 LT-mediated replication. However, for MCV ) and JC polyomavirus (Prins and Frisque, 2001) , sT coexpression markedly enhances LT-mediated viral DNA synthesis, although the mechanism for this effect is unknown. Like papillomaviruses, MCV is poorly transmissible in culture. Replication of genomic MCV clones Neumann et al., 2011; Schowalter et al., 2011) can be markedly enhanced by coexpression of a MCV sT from a heterologous promoter . While investigating the mechanism by which MCV sT synergistically enhances MCV LTdependent replication, we found that MCV sT targets the cellular SCF (complex of Skp1, Cul1 and F-Box protein) ubiquitin ligase protein complex, SCF Fbw7 . Fbw7 (F-box and WD repeat domain-containing 7, also known as FBXW7, CDC4, AGO, and SEL10) serves as the substrate recognition component for this multiprotein cullin-RING ubiquitin ligase complex that includes Fbw7, Skp1, Cul1 and Rbx1 (Welcker and Clurman, 2008) . The importance of Fbw7 in controlling cancer cell outgrowth has been highlighted by studies showing it to be dysregulated in breast cancer, colon cancer and T-cell acute lymphoblastic leukemia (Maser et al., 2007; Wood et al., 2007) . Numerous cancer-associated mutations of Fbw7 also have been reported in various cancers (Akhoondi et al., 2007) , and loss of Fbw7 function results in tumorigenesis and genetic instability (Mao et al., 2004; . Fbw7 recognition promotes phosphorylation-dependent degradation in many proto-oncogenes, including cyclin E (Koepp et al., 2001; Strohmaier et al., 2001 ), c-Myc (Welcker et al., 2004; Yada et al., 2004) , c-Jun (Nateri et al., 2004) , Notch (Gupta-Rossi et al., 2001; Oberg et al., 2001; Wu et al., 2001) , mTOR (Mao et al., 2008) , MCL-1 (Inuzuka et al., 2011; Wertz et al., 2011) , and NF-kB2 (p100/p52) (Arabi et al., 2012; Fukushima et al., 2012) , indicating that Fbw7 is a critical nexus for diverse signaling pathways regulating cell proliferation and tumor suppression.
We show here that MCV LT oncoprotein level is regulated by Fbw7. MCV sT, through inhibition of Fbw7, enhances MCV genome replication by promoting accumulation of the MCV LT oncoprotein. This targeting of SCF Fbw7 is mediated through an LT-stabilization domain (LSD) that maps to residues 91-95 and is predicted to be on the opposite molecular face of sT from its PP2A-targeting site. Mutation of the LSD not only abolishes MCV sT stabilization of MCV LT but eliminates sT-induced rodent cell transformation, inhibits viral replication and prevents MCV sT induction of several cellular oncoproteins, including cMyc and cyclin E. These effects are independent of MCV sT binding to PP2A. In MCC tumor cells, having defective MCV genomes incapable of replication, MCV sT stabilizes and increases steady-state levels of viral and cellular oncoproteins. Fbw7 knockdown alone does not rescue the transforming phenotype for the MCV sT LSD mutant protein, however, suggesting that the LSD targeting domain also affects a broader range of cell signaling pathways.
RESULTS

MCV sT enhances LT-mediated MCV origin replication through a PP2A-independent mechanism
Using an MCV origin replication assay , we tested various MCV sT constructs for their effect on MCV LT-dependent origin replication activity (Figure 1 ). Separate sT constructs and full length, wild type MCV LT (or empty vector) plasmids were cotransfected into 293 cells together with a plasmid containing the MCV replication origin (Ori339(97)) . No replication of the origin plasmid occurs in the absence of MCV LT ( Figure 1A , lane 1). Expression of MCV LT ( Figure 1A , lane 2) activates baseline origin plasmid replication, which is amplified ~5-fold by cotransfection of wildtype MCV sT ( Figure 1A , lane 3). This enhancement of MCV LT replication by sT is largely unaffected when wild-type MCV sT expression is substituted with expression of mutant MCV sT having alanine substitutions in amino acids R7 or L142 ( Figure 1A , lanes 4 and 5) that inhibit PP2A interaction (Shuda et al., 2011) , or an aspartate-asparagine substitution at D44 ( Figure 1A , lane 6) in the MCV sT DnaJ domain eliminating heat-shock protein (Hsc70) interactions ).
MCV sT is generated by read-through of the splice-donor site in exon1 (a.a. 1-79) to produce a unique sT C-terminus peptide encoded by exon1A (a.a. 80-186) ( Figure 1A ) Shuda et al., 2008) . SV40 sT is similarly generated from a 82 a.a. exon 1, which reads through splice site to generate a C-terminal region (a.a. 83-174). MCV sT and SV40 sT proteins are highly homologous to each other (33% a.a. identity by Basic Local Alignment Search Tool (BLAST) program). In contrast to MCV sT, SV40 sT does not cross-enhance MCV LT-mediated DNA replication despite conserved PP2A and Hsc domains ( Figure 1A , lane 7). However, a chimeric sT comprised of SV40 sT exon 1 (a.a. 1-82) and MCV exon1A (a.a. 80-186) designated SV40/MCV sT ( Figure 1A , lane 8) restored DNA replication activation, suggesting the responsible domain is encoded in the MCV sT C-terminus. The reverse chimeric construct (MCV/SV40 sT) comprised of N-terminus MCV exon1 (a.a. 1-79) and C terminus SV40 exon1A (a.a. 83-174) could not be evaluated due to protein instability. Notably, MCV sT constructs that activated MCV origin replication also correlatively enhanced levels of MCV LT protein expressed from a heterologous promoter (pcDNA6). SV40 sT, which increased MCV LT protein expression did not enhance MCV DNA replication ( Figure 1A , lane 7). In line with our observation that MCV sT affects MCV LT protein levels, increased LT expression was consistently detected in populations of cells co-expressing sT but not in cells expressing only LT by immunofluorescence ( Figure S1 ).
To map the MCV sT domain enhancing LT-dependent MCV DNA replication, we constructed sT mutants with sequential 5 amino acid deletions or 5 alanine substitutions in its C-terminal exon 1A. Deletion at residues 91-95 (sT.91-95Δ, Figure 1B , lane 5), as well as alanine substitution (sT.91-95A, Figure 1B , lane 6) ablated enhanced MCV DNA replication and reduced LT protein levels. Enhanced replication was also diminished compared to the wild-type sT protein ( Figure 1B Figure 1B, lane 3) . This, however, likely results from reduced stability of the mutant sT protein since that steady-state sT.86-90Δ protein level is reduced compared to wild-type sT. Alanine substitutions at a.a. 86-90 ( Figure 1B , lane 4) fully restored this mutant's protein stability and activation of MCV LT-mediated replication.
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The high homology between MCV sT and SV40 sT allowed us to model MCV sT (I-TASSER) by threading its sequence onto the SV40 sT crystal structure (PDB ID:2PF4, 2PKG) (Chen et al., 2007; Cho et al., 2007) . This predicts that the MCV sT amino acid 91-95 region, designated the LT-stabilization domain (LSD), forms a larger loop structure than the one present in the SV40 sT molecule (Figure 2 and Movie S1). The LSD is predicted to be on the opposing surface of the MCV sT from the PP2A-interaction region and distinct from the DnaJ domain (Movie S1), correlating with the mutation analysis in Figure 1A .
MCV sT synergistically enhances MCV LT-dependent virus replication
We next sought to determine if increased MCV LT protein accumulation by MCV sT contributes to MCV replication. Cotransfection of small amounts of wild type sT expression plasmid (0.1 µg) maximally activated LT expression ( Figure 3A ) and LT-dependent origin replication ( Figure S2A ). This is not due to enhanced transcription of the LT gene since sT does not increase LT mRNA levels ( Figure 3B ). These effects can be demonstrated with whole MCV genome replication as well. MCV sT expressed in trans markedly activates viral replication from the MCV-HF plasmid clone ( Figure 3C ) . The effect is lost using MCV sT having alanine substitutions in the LSD (MCV sT.LSD 91-95A ). In the MCV-positive MCC cell line MKL-2, knockdown of MCV sT was correlated with reduction in LT protein expression ( Figure S2B ).
MCV sT inhibits proteasomal degradation of MCV LT
To measure sT effects on LT stability, quantitative immunoblotting ( Figures 3D and S2C ) was used to measure LT abundance in the presence of the translation inhibitor cycloheximide (CHX). In the absence of sT, LT had a rapid turnover with a half-life (t 1/2 ) of 3-4 hrs and diminished to low levels within 24 hours after CHX addition. Coexpression of sT together with LT increased the t 1/2 for LT to >24 hours but did not significantly alter stability of a control protein (eGFP). Additional evidence that sT inhibits LT turnover was seen after treatment with the proteasome inhibitor MG132 ( Figure 3E ). MG132 treatment did not increase LT levels above those found with sT coexpression alone ( Figure 3E , lanes 5 and 6), consistent with both sT and MG132 acting to prevent LT proteolysis. In this same experiment, wild-type sT expression led to accumulation of LT protein after 24 hours of 0.1 mg/ml CHX treatment ( Figure 3E , lanes 8 and 9) which was not seen during expression of sT.LSD 91-95A ( Figure 3E , lane 10). MG132 markedly increases sT and sT.LSD 91-95A levels ( Figure 3E , lanes 6 and 7) indicating that sT itself is subject to rapid proteasomal turnover.
SCF Fbw7 binds to and promotes turnover of MCV LT
SV40 LT is a pseudo-substrate for Fbw7 (Welcker and Clurman, 2005 ) and so we examined potential interaction between MCV LT and Fbw7 by immunoprecipitation ( Figure 4A and 4C). When MCV LT ( Figure 4A ) or sT ( Figure 4B ) are expressed in U2OS cells, specific coimmunoprecipitation with HA-Fbw7 was readily detectable with each viral protein. For sT, mutation within the LSD eliminated the sT-Fbw7 interaction. MCV LT, however, is a poly-phosphoprotein with multiple potential consensus F-box binding motifs (S/TPXX) that could serve as recognition sequences for SCF Fbw7 . Mutation analyses to define the Fbw7 recognition site(s) on LT are ongoing, and are complicated by multiple phosphorylationdependent turnover pathways for the LT protein (data not shown), but preliminary analyses suggest that this domain is likely to be conserved in most tumor-derived MCV strains. In 293 cells, Fbw7 was rapidly turned over and required MG132 treatment for robust detection.
Consistent with this, LT and sT interaction with Fbw7 was only revealed in the presence of MG132 ( Figures 4C and 4D ).
Fbw7 targeting of MCV LT is inhibited by coincident expression of MCV sT protein as shown in Figure 4E . 293 cells expressing HA-tagged Fbw7 were treated with MG132 and then immunoprecipitated using an HA-tagged antibody. LT immunoprecipitated with HAFbw7 ( Figure 4E , lane 5) but this interaction is markedly diminished by expression of sT together with LT ( Figure 4E , lane 6), which can be reversed by mutation to the sT LSD ( Figure 4E, lane 7) . Fbw7 immunoprecipitation of c-Myc protein (Yada et al., 2004) , was performed as an immunoprecipitation control ( Figure 4E, lane 4) . In addition, an arginine mutant of human Fbw7 R465C, which is defective in binding to its substrate (Akhoondi et al., 2007) was examined for LT binding. MCV LT interacts with wild type (wt) Fbw7 but it loses its binding with R465C mutant (Figure S3 ).
To examine whether the ubiquitylation status of LT is Fbw7-dependent, LT and a vector containing CMV promoter-driven HA-ubiquitin were cotransfected in HCT116 wt and Fbw7 (−/−) cells. Immunoprecipitation of LT followed by immunoblot analysis of the HAubiquitin showed efficient LT ubiquitylation found in cells preserving a functional Fbw7 gene and reduced ubiquitylation in Fbw7 (−/−) cells ( Figure S4A ). Ubiquitylation of LT is also reduced by sT overexpression. Proteasome inhibition using MG132 increased the amount of ubiquitin chains bound to LT and is reduced by sT suggesting that MCV sT inhibits LT ubiquitylation by prohibition of Fbw7 E3 ligase activity.
Consistent with sT targeting Fbw7 to enhance steady-state LT expression, knockdown of cellular Fbw7 by lentiviral transduction also decreased turnover rates of LT protein ( Figure  5A ). In these experiments, we were unable to measure endogenous Fbw7 levels using commercial antibodies and so knockdown efficacy was monitored by ectopic HA-Fbw7 expression. Whole virus replication was also enhanced by Fbw7 knockdown ( Figure 5B ). Cells transduced by scrambled (Scr) or shFbw7 lentiviruses were transfected with MCV-HF genome and MCV replication was assessed. Fbw7 knockdown alone enhanced virallyexpressed LT protein and VP1 protein expression and virus genome replication. Coexpression of sT protein ( Figure 5B , lanes 4) markedly increased viral replication that was further increased by simultaneous knockdown of Fbw7 ( Figure 5B , lanes 8). In comparison, MCV-Rep − ( Figure 5B , lanes 2 and 6) is a replication defective control virus having a point mutation in its replication origin . As expected, MCV-Rep − showed no late protein or genome replication after Fbw7 knockdown but knockdown did increase MCV-Rep − LT protein levels indicating that this effect was not dependent on virus replication. These Fbw7 knockdown results were confirmed using HCT116 cells engineered for deletion of the Fbw7 gene . Transient LT protein was barely detected in homozygous Fbw7 wild-type (+/+) cells but increased 10-fold when the same amount of LT DNA was transfected into homozygous (−/−) Fbw7 null cells ( Figure 5C ). Intermediate LT protein levels were detected in cells with hemizygous (+/−) Fbw7 status. Similarly, LT expression from the MCV-HF virus was minimal in wild-type HCT116 cells but markedly increased in Fbw7-null HCT116 cells ( Figure 5D ). MG132 proteasome inhibition increased LT expression from virus in wild-type but not in Fbw7-null HCT116 cells.
The effect of sT expression on the cellular Fbw7 oncoprotein target c-Myc was examined in Rat-1 fibroblasts transduced with empty vector, sT or sT.LSD 91-95A , sT.L142A, SV40 sTexpressing lentiviruses, and treated with CHX ( Figure 5E ). Both sT and sT.L142A increased c-Myc expression and prolonged its turnover, an effect which is lost for sT.LSD 91-95A . Cyclin D1, a target of SCF Skp2 , SCF Fbx4 and SCF Fbw8 (Lin et al., 2006; Okabe et al., 2006; Yu et al., 1998) , was unaffected by sT expression. Overexpressed HA-Fbw7 increased turnover of Flag-labeled c-Myc in 293 cells and this could be fully reversed by simultaneous expression of MCV sT ( Figure 5F ). Cyclin E turnover is also reduced by sT but not sT.LSD 91-95A expression ( Figure S4B ).
MCV sT activates 4E-BP1 hyperphosphorylation required for MCV sT-induced transformation (Shuda et al., 2011) , but unlike c-Myc, we did not find evidence that 4E-BP1 is regulated by Fbw7 ( Figure S4C ) suggesting that sT effects on 4E-BP1 hyperphosphorylation are independent of Fbw7 targeting.
The sT LSD domain is required for sT-induced, PP2A-independent Rat-1 cell transformation Focus formation and soft-agar colony growth assays were used to determine cell transformation of Rat-1 ( Figure 6A ) and NIH3T3 cells ( Figure S5 ) after lentiviral transduction with various sT genes (Shuda et al., 2011) . Only wild-type MCV sT and sT.L142A reproducibly formed colonies after 3 weeks of growth in soft agar. In contrast, the MCV sT.LSD 91-95A mutation ablated transforming activity. SV40 sT had no transforming activity, as previously described (Chang et al., 1984) . These differences occur in the setting of comparable levels of sT expression for the different constructs ( Figure 6B ). As seen in Figure 6C , the sT.LSD 91-95A mutation did not affect sT binding to endogenous PP2Ac in Rat-1 cells whereas the sT.L142A mutation eliminated PP2Ac interaction reaffirming that MCV sT transforms cells through a PP2A-independent mechanism (Shuda et al., 2011) . We did not, however, find that SCF Fbw7 targeting by MCV sT is sufficient to transform cells, and LSD-mutant sT protein was not complemented by lentiviral knockdown of Fbw7 protein ( Figure S6 ) in rodent cell transformation (Figure 7 ).
DISCUSSION
MCV sT is a viral oncoprotein that causes cell transformation as measured by focus formation assays and anchorage-independent growth of NIH3T3 and Rat-1 cells. This effect is independent of MCV LT (Shuda et al., 2011) . MCV sT also enhances MCV LT replication functions Kwun et al., 2009; Schowalter et al., 2011) . We show here that MCV achieves this by targeting the SCF Fbw7 holoenzyme through the LSD encoded by sT exon1A.
We have previously shown that sT induces hyper-phosphorylated 4E-BP1, a regulator of cap-dependent translation, during transformation (Shuda et al., 2011) . This is not dependent on Fbw7 targeting by sT ( Figure S4C ) and so the relationship between these two sTregulated transformation pathways remains unclear. Fbw7 knockdown alone fails to transform Rat-1 cells expressing sT.LSD 91-95A and so it is likely that LSD targeting has broader effects than inhibition of SCF Fbw7 alone. Further, a survey of other known cellular Fbw7 targets such as Mcl-1 (data not shown) did not reveal consistent turnover inhibition, making it likely that the role of sT in transformation are more complex than Fbw7 targeting alone.
The LT phosphorylation sites that serve as recognition motifs for SCF Fbw7 have not yet been mapped but seem to be retained in many of the tumor-derived LT proteins (data not shown). Physiological substrates of Fbw7 hold the phosphodegron with a wide range of binding affinities and retain multiple low-affinity degrons in some case, for example, Sic1 (Nash et al., 2001) , which may allow fine-tuning of protein proteolysis. Comparing c-Myc, MCV LT binding to Fbw7 is predicted to be weak and low affinitive, presumably with multiple binding sites (Figure 4) . Dimerization of Fbw7 is known to be required for the turnover of low-affinity substrates, possibly facilitating the degradation by multi-recruitment of E2 ubiquitin conjugase (Welcker and Clurman, 2007) , which might be the case in LT degradation. Given the large number of potential phosphorylation sites present in LT, degradation might be triggered by multisite sequential phosphorylation events to induce binding to the SCF ubiquitin ligase complex, SCF Fbw7 . Both MCV LT and sT interact with Fbw7 but we cannot exclude the possibility that this might be a bridging effect mediated by direct sT targeting of other SCF complex proteins (e.g., Skp1, Cul-1 or Rbx-1) or an indirect inhibitory effect by sT on the recruitment of Fbw7 dimers to LT. Further, it is possible that LT not only has complex interaction with Fbw7 but is regulated by other E3 ligases affected by sT: LT is ubiquitylated in Fbw7(−/−) cells and sT inhibits the ubiquitylation of LT in Fbw7(−/−) cells ( Figure S4A ). Although LT is degraded as a target of SCF Fbw7 , sT readily interacts with Fbw7 through its LSD domain without itself being targeted by Fbw7 at this site.
MCV hijacking of the SCF Fbw7 circuitry nonetheless has important consequences since this may increase expression of viral LT as well as other cellular oncoproteins such as c-Myc and cyclin E. The reasons why MCV has evolved such a complex mechanism to autoregulate LT levels through SCF Fbw7 targeting remain enigmatic. sT is an alternatively spliced isoform from LT and is expected to be expressed together with LT under most cellular conditions. sT targeting of SCF Fbw7 can be expected to perpetuate phosphorylated forms of LT that would otherwise be marked for rapid turnover. This is functionally reminiscent of SV40 LT, which interacts with Fbw7 to competitively interfere with substrate turnover (Welcker and Clurman, 2005 ) to achieve similar molecular end results. Other viral proteins, including HPV E7 (Oh et al., 2004) , KSHV vIRF3 (LANA2) (Baresova et al., 2012) , EBV EBNA3C (Knight et al., 2005) , HPV E2 (Bellanger et al., 2010) and adenovirus E1A (Isobe et al., 2009) inhibit SCF Fbw7 or related target F-box protein complexes, suggesting that this is a common theme among persistent DNA viral infections.
PP2A targeting is another common feature of polyomavirus early proteins (Campbell et al., 1995; Pallas et al., 1990; Sontag et al., 1993) and is critical in defined gene transformation of human cells using SV40 early proteins (Hahn et al., 1999; Hahn et al., 2002) . PP2A actually represents a large class of protein phosphatases, comprising hundreds of different phosphatase holoenzymes that use different combinations of PP2A A, B and C subunits to target substrate for dephosphorylation. MCV retains PP2A interacting domains but these domains are predicted to be distinct from the region targeting SCF Fbw7 . The LSD, required for MCV sT to transform cells, is on the opposite molecular surface to the PP2A docking domain in MCV sT (Figure 2 and Movie S1). This loop is absent from SV40 sT, potentially explaining the inability of SV40 sT to synergistically promote MCV LT-mediated replication (Figure 2 and Movie S1).
Merkel cell carcinoma is a dead-end for the MCV lifecycle since the clonally-integrated virus is no longer capable of producing infectious virions from tumor cells. MCV targeting of SCF Fbw7 through the MCV sT LSD appears to be a key feature in the normal viral lifecycle that allows the virus to persist and replicate as a harmless viral skin infection (Tolstov et al., 2011) . Under conditions in which MCV initiates human tumor cell transformation, however, sT LSD-mediated targeting of viral and cellular oncoproteins may contribute to promotion of an aggressive human malignancy.
EXPERIMENTAL PROCEDURES Plasmids
Codon-optimized, commercially synthesized MCV LT and sT antigen sequences were cloned into pcDNA6/V5/His vector (Invitrogen) with a modified multiple cloning site (MCS). All LT and sT constructs used are untagged. HA-Fbw7 and Flag-cMyc (Yada et al., 2004 ) plasmids were kindly provided by Dr. Nakayama (Kyushu University, Japan). See also supplemental experimental procedures.
Cell lines
293 or U2OS cells were cultured in DMEM with 10% fetal bovine serum (FBS) from Sigma. MCV positive Merkel cell carcinoma (MCC) cell line MKL-2 was cultured in RPMI with 10% FBS. HCT116 cells (hCDC4 +/+, +/−, −/−), kindly provided by Dr. Bert Vogelstein and obtained from Johns Hopkins University Genetic Resources Core Facility, were grown in McCoy's 5A medium with 10% FBS. Rat-1 cells and NIH3T3 cells were maintained in DMEM with 5% FBS or 10% calf serum, respectively.
MCV Origin Replication Assay
The MCV replication origin assay was described previously Kwun et al., 2009) . Briefly, 293 cells were transfected with T antigen expression vector (LT/sT, 0.3 µg), pMCV-Ori339(97) (0.3 µg) by Lipofectamine 2000 (Invitrogen) in 12-well plates. Fortyeight hours after transfection, episomal DNA was collected by salt-precipitation. DNA was double-digested with BamHI and DpnI, then subjected to Southern hybridization or qRT-PCR.
Structural modeling
The model of MCV sT structure was generated using the I-TASSER server (http:// zhanglab.ccmb.med.umich.edu/I-TASSER/) based on SV 40 sT homolog structures (PDB ID: 2PF4, 2PKG). The figures were generated using PyMOL (http://www.pymol.org/).
Quantitiative Real-time RT-PCR Analysis
293 cells were transfected with LT or sT expression (0.3 µg) constructs and total RNA was isolated 2 days after transfection using TRIzol LS reagent (Invitrogen). qRT-PCR was carried out with total RNA (0.1 µg) and iScript one-step RT-PCR kit (Bio-Rad) using a SmartCycler (Cepheid) according to the manufacturer's protocol. Primer sequences used for LT and GAPDH cDNA detection are described in Table S1 .
Immunoprecipitation (IP) and immunoblotting
Cells were lysed in IP buffer (Tris-HCl (pH 7.4), 150 mM NaCl, 2% Triton X-100) freshly supplemented with protease inhibitor cocktail (Roche), 1 mM PMSF, 5 mM NaF, and 2.5 mM NaVO 3 . Lysates were incubated with specific antibody and followed by immunoblotting to detect interacting proteins. See also supplemental experimental procedures.
Lentiviral/retroviral infection for short hairpin RNA knockdown
Short hairpin RNAs (shRNA) targeting Fbw7 were designed (Table S1 ) and cloned into lentiviral vector pLKO.1 (Addgene) using AgeI and EcoRI. A control shRNA construct was obtained from Addgene (1864). shRNA transfected cells were selected with puromycin (2 µg/ml) for 4 days after infection. See also supplemental experimental procedures.
Soft agar colony formation assay
Rat-1 stably expressing small T antigens were seeded over a 0.6% agar layer in 6-well plate (2.5×10 4 cells/well) and grown for 3 weeks. Colonies were photographed and counted after 0.05% crystal violet staining as described previously (Shuda et al., 2011) . All experiments were performed in triplicate.
HIGHLIGHTS -
MCV sT prevents turnover of the MCV helicase LT to enhance viral DNA replication.
-
The MCV sT domain, LSD, inhibits MCV LT turnover by targeting the cellular ligase SCF Fbw7 .
-MCV sT inhibition of SCF Fbw7 also attenuates the degradation of cellular oncoproteins.
-MCV sT LSD mediates rodent cell transformation. , and SV40 sT. Both wild-type MCV sT and sT.L142A reproducibly formed colonies after 3 weeks of growth in soft agar, whereas the MCV sT.LSD 91-95A mutation ablated transforming activity. Cells were stained with crystal violet (upper). Transformation-associated foci were photographed (×40) (middle) and colony number per high-power field was counted (bottom). All assays were performed in triplicate. Error bars represent SEM; n = 3. (B) All sT constructs show similar levels of expression in Rat-1 cell lines from transformation assays. Stable sT expressing cell lines used for soft agar assay were tested by immunoblotting with mixed antibodies, CM8E6 and pAb419 for MCV and SV40 sT detection, respectively. (C) LSD mutation does not affect sT binding to PP2A. Immunoprecipitation analysis was performed to measure PP2A binding capacity of sT mutants stably expressed in Rat-1. Either MCV sT antibody (CM8E6) or SV40 sT antibody (pAb419) was used for immunoprecipitation of sT and endogenous PP2A was detected. The non-transforming LSD mutant sT interacts with PP2A, similar to wild type sT. A PP2A binding mutant L142A ablates its binding to PP2A but retains its transforming activity ( Figure 6A ). These data indicate that the sT transforming activity is PP2A-independent. SV40 sT was used as a positive control of PP2A binding and a negative control for the transformation. See also Figure S5 .
Figure 7. Fbw7 knockdown is insufficient for MCV sT-induced transformation
Rat-1 cells were stably transduced with two lentiviral shRNAs (sh Fbw7.1 and shFbw7.2) targeting the rat specific Fbw7. Empty vector lentivirus, sT.LSD 91-95A or wild type MCV sT (sT.wt) were individually transduced into Fbw7 knockdown cells and subjected to transformation assays. Transformation-induced foci were stained with crystal violet (upper). Colonies formed in soft-agar (middle) were counted to quantitate transformation activity (bottom). Error bars represent SEM; n = 3. The SCF Fbw7 targeting by Fbw7 knockdown is not sufficient for rodent cell transformation but decreases soft agar growth induced by MCV sT. Fbw7 knockdown level was documented in Figure S6 .
